GSK has declared a further multi-million pound UK investment less than a week after the pharmaceutical giant announced a £275m investment into its UK manufacturing sites.
GSK has signed an agreement with Verily Life Sciences (formerly Google Life Sciences) to form Galvani Bioelectronics, a new company dedicated to the development of bioelectronic medicines.
…
Related articles: GSK pledge to invest in UK manufacturing AstraZeneca and pharma bodies urge funding for antibiotics research Healthcare innovation to help save NHS £millions
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
